ClinVar Miner

Submissions for variant NM_002180.3(IGHMBP2):c.1295C>T (p.Ala432Val)

gnomAD frequency: 0.00009  dbSNP: rs370414354
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000236000 SCV000292996 uncertain significance not provided 2015-08-05 criteria provided, single submitter clinical testing The A432V variant in the IGHMBP2 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The A432V variant was not observed at any significant frequency in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common variant in these populations. The A432V variant is a conservative amino acid substitution, which occurs at a position that is not conserved across species. In silico analysis predicts this variant likely does not alter the protein structure/function. We interpret A432V as a variant of unknown significance.
Fulgent Genetics, Fulgent Genetics RCV000763763 SCV000894658 uncertain significance Autosomal recessive distal spinal muscular atrophy 1; Charcot-Marie-Tooth disease axonal type 2S 2018-10-31 criteria provided, single submitter clinical testing
Invitae RCV000763763 SCV000956167 likely benign Autosomal recessive distal spinal muscular atrophy 1; Charcot-Marie-Tooth disease axonal type 2S 2023-12-30 criteria provided, single submitter clinical testing
Ambry Genetics RCV002379045 SCV002695493 uncertain significance Inborn genetic diseases 2020-11-12 criteria provided, single submitter clinical testing The p.A432V variant (also known as c.1295C>T), located in coding exon 9 of the IGHMBP2 gene, results from a C to T substitution at nucleotide position 1295. The alanine at codon 432 is replaced by valine, an amino acid with similar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Revvity Omics, Revvity RCV000236000 SCV003813289 uncertain significance not provided 2019-07-10 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.